Active ingredientCannabidiolCat. No. P-C021-001CAS 13956-29-1Family · Pharmaceutical analytical standards
Cannabidiol
A non-psychoactive cannabinoid from hemp (Cannabis sativa), first isolated in 1940; in 2018 it was approved in the United States as a medicine for two rare and severe childhood epilepsies, Lennox-Gastaut and Dravet syndromes. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its chemical structure was worked out only in 1963, more than twenty years after its isolation, by the group of Israeli chemist Raphael Mechoulam.
Go to the active ingredient →Active ingredientCannabidiolCat. No. P-C021-001CAS 13956-29-1
Pharmacopoeial impurityCannabidiol EP Impurity JCat. No. P-C021-002CAS 35482-50-9
Pharmacopoeial impurityCannabidiol EP Impurity ECat. No. P-C021-003CAS 137252-25-6
Impurity7-Carboxy cannabidiolCat. No. P-C021-004CAS 1101886-13-8
Isotopically labelledCannabidiol Impurity 1-d9Cat. No. P-C021-005CAS 136765-52-1
Isotopically labelledCannabidiol-d3Cat. No. P-C021-006CAS 1435783-16-6
Isotopically labelledCannabidiol-d9Cat. No. P-C021-007CAS 2435593-04-5
Isotopically labelleddelta-9-Tetrahydrocannabinol-d3Cat. No. P-C021-008CAS 81586-39-2
Impuritydelta-8-TetrahydrocannabinolCat. No. P-C021-009CAS 5957-75-5
Impurity(1S,6R)-Cannabidiol EpoxideCat. No. P-C021-010CAS 2345666-26-2
Impurity11-Hydroxy-delta 8-TetrahydrocannabinolCat. No. P-C021-011CAS 28646-40-4
ImpurityCannabidiol Impurity 1Cat. No. P-C021-012CAS 56354-06-4
Impurity4-Bromo-CannabidiolCat. No. P-C021-014CAS 112639-10-8
ImpurityCannabichromeneCat. No. P-C021-017CAS 20675-51-8
ImpurityCannabichromenic AcidCat. No. P-C021-018CAS 185505-15-1
ImpurityCannabicyclolic AcidCat. No. P-C021-019CAS 40524-99-0
ImpurityCannabidibutolCat. No. P-C021-020CAS 60113-11-3
ImpurityCannabidiol Dihydroxy ImpurityCat. No. P-C021-021
ImpurityCannabidiol Impurity 2Cat. No. P-C021-022
ImpurityCannabidiol Impurity 3Cat. No. P-C021-023CAS 74716-09-9
ImpurityCannabidiol Impurity 4Cat. No. P-C021-024CAS 22972-51-6
ImpurityCannabidiol Impurity 5Cat. No. P-C021-025CAS 16850-65-0
ImpurityCannabidiol Impurity 6Cat. No. P-C021-026
ImpurityCannabidiolic AcidCat. No. P-C021-027CAS 1244-58-2
ImpurityCannabielsoinCat. No. P-C021-028CAS 52025-76-0
ImpurityCannabigerovarinic AcidCat. No. P-C021-029CAS 64924-07-8
ImpurityCannabinolCat. No. P-C021-030CAS 521-35-7
ImpurityCannabinolic AcidCat. No. P-C021-031CAS 2808-39-1
ImpurityCannabitriolCat. No. P-C021-032CAS 74184-29-5
ImpurityCannabidiol EnantiomerCat. No. P-C021-033CAS 74219-29-7
Impuritycis-delta-9-TetrahydrocannabinolCat. No. P-C021-034CAS 6087-73-6
Impuritydelta-11-TetrahydrocannabinolCat. No. P-C021-036CAS 27179-28-8
Impuritydelta-9-Tetrahydrocannabinolic AcidCat. No. P-C021-038CAS 23978-85-0
ImpurityHydroxy CannabidiolCat. No. P-C021-039CAS 66052-28-6
ImpurityMethyl CannabidiolateCat. No. P-C021-040CAS 55658-71-4
ImpurityMethyl olivetolateCat. No. P-C021-041CAS 58016-28-7
ImpurityOrtho-delta 8-TetrahydrocannabinolCat. No. P-C021-044CAS 22972-59-4
Pharmacopoeial impurityCannabidiol EP Impurity ACat. No. P-C021-046CAS 24274-48-4No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceCannabidiol CRSEDQM code Y0002429Family CannabidiolImpurityCannabidiol impurity J CRSEDQM code Y0002436Family CannabidiolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.